litlas
ログインアカウント作成

Andrea Rubbert‐Roth

2008–2026 年に発表

別表記
Andrea Rubbert-Roth
60
論文数
20,129
被引用数
43
h 指数
60
i10 指数

被引用数

Andrea Rubbert‐Roth の年別被引用数1994 年: 被引用 2 件2005 年: 被引用 1 件2007 年: 被引用 1 件2008 年: 被引用 12 件2009 年: 被引用 38 件2010 年: 被引用 45 件2011 年: 被引用 63 件2012 年: 被引用 72 件2013 年: 被引用 91 件2014 年: 被引用 161 件2015 年: 被引用 194 件2016 年: 被引用 170 件2017 年: 被引用 243 件2018 年: 被引用 187 件2019 年: 被引用 716 件2020 年: 被引用 942 件2021 年: 被引用 890 件2022 年: 被引用 720 件2023 年: 被引用 463 件2024 年: 被引用 777 件2025 年: 被引用 364 件2026 年: 被引用 12 件1995〜2004 年は被引用が無いため表示していません2006 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,334 件、この内訳の 14.8%イギリス: 引用元論文 782 件、この内訳の 8.7%ドイツ: 引用元論文 577 件、この内訳の 6.4%中国: 引用元論文 575 件、この内訳の 6.4%イタリア: 引用元論文 494 件、この内訳の 5.5%オランダ: 引用元論文 473 件、この内訳の 5.2%フランス: 引用元論文 420 件、この内訳の 4.7%日本: 引用元論文 418 件、この内訳の 4.6%カナダ: 引用元論文 323 件、この内訳の 3.6%スペイン: 引用元論文 299 件、この内訳の 3.3%スイス: 引用元論文 262 件、この内訳の 2.9%オーストリア: 引用元論文 222 件、この内訳の 2.5%
0%14.8%その他 31.4%

機関

分野

  • Medicine80.8%
  • Immunology and Microbiology9.5%
  • Biochemistry, Genetics and Molecular Biology6.3%
  • Neuroscience0.8%
  • Pharmacology, Toxicology and Pharmaceutics0.8%
  • Health Professions0.5%
  • その他1.3%

トピック

  • Rheumatoid Arthritis Research and Therapies19.3%
  • Spondyloarthritis Studies and Treatments7.3%
  • Autoimmune and Inflammatory Disorders Research6.7%
  • Systemic Lupus Erythematosus Research5.8%
  • Psoriasis: Treatment and Pathogenesis3%
  • Biosimilars and Bioanalytical Methods2.3%
  • その他55.6%

共著者

全論文

検索で開く
  1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

    著者: Josef S Smolen, Robert Landewé, Sytske Anne Bergstra, Andreas Kerschbaumer, Alexandre Sepriano, Daniel Aletaha, Roberto Caporali, Christopher J Edwards, Kimme L Hyrich, Janet Pope, Savia de Souza, Tanja Stamm, Tsutomu Takeuchi, Patrick Verschueren, Kevin Winthrop, Alejandro Balsa, Joan M. Bathon, Maya H Buch, Gerd R Burmester, Frank Buttgereit, Myrna Cardiel, Katerina Chatzidionysiou, Cătălin Codreanu, Maurizio Cutolo, Alfons A den Broeder, Khadija El Aoufy, Axel Finckh, João Eurico Fonseca, Jacques‐Eric Gottenberg, Espen A. Haavardsholm, Annamaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B. McInnes, Eduardo Mysler, Peter Nash, Gyula Poór, Gorica Ristić, Felice Rivellese, Andrea Rubbert‐Roth, Hendrik Schulze‐Koops, Nikolay Stoilov, Anja Strangfeld, Annette H M van der Helm–van Mil, Elsa van Duuren, T. P. M. Vliet Vlieland, René Westhovens, Désirée van der Heijde - Annals of the Rheumatic Diseases 2022 被引用: 1,788

  2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    著者: Josef S Smolen, Robert Landewé, Johannes Bijlsma, Gerd Burmester, Katerina Chatzidionysiou, Maxime Dougados, J. Nam, Sofía Ramiro, Marieke Voshaar, Ronald van Vollenhoven, Daniel Aletaha, Martin Aringer, Maarten Boers, Christopher D. Buckley, Frank Buttgereit, Vivian P. Bykerk, Mario Cardiel, Bernard Combe, Maurizio Cutolo, Yvonne van Eijk‐Hustings, Paul Emery, Axel Finckh, Cem Gabay, Juan J. Gómez‐Reino, Laure Gossec, J.-E. Gottenberg, Johanna M W Hazes, T. Huizinga, Meghna Jani, Д. Е. Каратеев, Marios Kouloumas, Tore Kvien, Zhanguo Li, Xavier Mariette, Iain B. McInnes, Eduardo Mysler, Peter Nash, Karel Pavelká, Gyula Poór, Christophe Richez, Piet L. C. M. van Riel, Andrea Rubbert‐Roth, Kenneth G. Saag, José António Pereira da Silva, Tanja Stamm, Tsutomu Takeuchi, René Westhovens, Maarten de Wit, Désirée van der Heijde - Annals of the Rheumatic Diseases 2017 被引用: 5,775

  3. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

    著者: Josef S Smolen, Robert Landewé, J. W. J. Bijlsma, Gerd R Burmester, Maxime Dougados, Andreas Kerschbaumer, Iain B. McInnes, Alexandre Sepriano, Ronald van Vollenhoven, Maarten de Wit, Daniel Aletaha, Martin Aringer, Johan Askling, Alejandro Balsa, Maarten Boers, Alfons A den Broeder, Maya H Buch, Frank Buttgereit, Roberto Caporali, Myrna Cardiel, Diederik De Cock, Cătălin Codreanu, Maurizio Cutolo, Christopher J Edwards, Yvonne van Eijk‐Hustings, Paul Emery, Axel Finckh, Laure Gossec, Jacques‐Eric Gottenberg, Merete Lund Hetland, T. Huizinga, Marios Koloumas, Zhanguo Li, Xavier Mariette, Ulf Müller‐Ladner, Eduardo Mysler, José António Pereira da Silva, Gyula Poór, Janet Pope, Andrea Rubbert‐Roth, Adeline Ruyssen‐Witrand, Kenneth G. Saag, Anja Strangfeld, Tsutomu Takeuchi, Marieke Voshaar, René Westhovens, Désirée van der Heijde - Annals of the Rheumatic Diseases 2020 被引用: 2,766

  4. Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial

    著者: Mark C. Genovese, Roy Fleischmann, Bernard Combe, Stephen Hall, Andrea Rubbert‐Roth, Ying Zhang, Yijie Zhou, Mohamed‐Eslam F. Mohamed, Sebastian Meerwein, Aileen L. Pangan - The Lancet 2018 被引用: 443

  5. Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis

    著者: Andrea Rubbert‐Roth, Jeffrey Enejosa, Aileen L. Pangan, Boulos Haraoui, Maureen Rischmueller, Nasser Khan, Ying Zhang, Naomi Martin, Ricardo Machado Xavier - New England Journal of Medicine 2020 被引用: 298

  6. Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial

    著者: Jürgen Rech, Koray Taşçılar, Melanie Hagen, Arnd Kleyer, Bernhard Manger, Verena Schoenau, Axel J. Hueber, Stefan Kleinert, Xenofon Baraliakos, Jürgen Braun, Uta Kiltz, Martin Fleck, Andrea Rubbert‐Roth, David M. Kofler, Frank Behrens, Martin Feuchtenberger, M. Zaenker, Reinhard Voll, Nils Venhoff, Jens Thiel, Cornelia Glaser, Eugen Feist, Gerd R Burmester, Kirsten Karberg, Johannes Strunk, Juan D. Cañete, Ladislav Šenolt, Mária Filková, Esperanza Naredo, Raquel Largo, Gerhard Krönke, Maria Antonietta D’Agostino, Mikkel Østergaard, Georg Schett - The Lancet 2024 被引用: 134

  7. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

    著者: Josef S Smolen, André Beaulieu, Andrea Rubbert‐Roth, César Ramos-Remus, J Rovenský, Emma Alecock, Thasia Woodworth, Rieke Alten - The Lancet 2008 被引用: 1,403

  8. The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus

    著者: Tobias Alexander, Ramona Sarfert, Jens Klotsche, Anja A. Kühl, Andrea Rubbert‐Roth, Hannes-Martin Lorenz, Jürgen Rech, Bimba F. Hoyer, Qingyu Cheng, Aderajew Waka, Adriano Taddeo, Michael S. Wiesener, Georg Schett, Gerd‐Rüdiger Burmester, Andreas Radbruch, Falk Hiepe, Reinhard Voll - Annals of the Rheumatic Diseases 2015 被引用: 363

  9. Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update

    著者: Daniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, Christian Dejaco, Maxime Dougados, Iain B. McInnes, Naveed Sattar, Tanja Stamm, Tsutomu Takeuchi, Michael Trauner, Désirée van der Heijde, Marieke Voshaar, Kevin Winthrop, Angelo Ravelli, Neil Betteridge, Gerd R Burmester, J. W. J. Bijlsma, Vivian P. Bykerk, Roberto Caporali, Ernest Choy, Cătălin Codreanu, Bernard Combe, Mary K. Crow, Maarten de Wit, Paul Emery, Roy Fleischmann, Cem Gabay, Merete Lund Hetland, Kimme L Hyrich, Annamaria Iagnocco, John D. Isaacs, Joel M. Kremer, Xavier Mariette, Peter A. Merkel, Eduardo Mysler, Peter Nash, Michael T. Nurmohamed, Karel Pavelká, Gyula Poór, Andrea Rubbert‐Roth, Hendrik Schulze‐Koops, Anja Strangfeld, Yoshiya Tanaka, Josef S Smolen - Annals of the Rheumatic Diseases 2022 被引用: 69

  10. Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper

    著者: Robert Spiera, Sebastian Unizony, Kenneth J. Warrington, Jennifer Sloane, Angeliki Giannelou, Michael C. Nivens, Bolanle Akinlade, Wanling Wong, Rafia Bhore, Yong Lin, Frank Buttgereit, Valérie Devauchelle‐Pensec, Andrea Rubbert‐Roth, George D. Yancopoulos, Frédéric Marrache, Naimish Patel, Bhaskar Dasgupta - New England Journal of Medicine 2023 被引用: 113

  11. Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

    著者: Désirée van der Heijde, James Cheng‐Chung Wei, Maxime Dougados, Philip J. Mease, Atul Deodhar, Walter P. Maksymowych, Filip Van den Bosch, Joachim Sieper, Tetsuya Tomita, Robert Landewé, Fangyi Zhao, Eswar Krishnan, David H. Adams, Beth A. Pangallo, Hilde Carlier, Melvin Churchill, Kathleen P. Flint, Geoffrey Gladstein, Maria Greenwald, Mary P. Howell, Akgun Ince, Jeffrey Kaine, Daksha Mehta, Eric Peters, Roel Querubin, John D. Reveille, Richard Roseff, Roger J. Diegel, Christine Thai, Louis Bessette, Frédéric Morin, Proton Rahman, Aaron Alejandro Barrera Rodriguez, Fidencio Cons-Molina, Sergio Duran Barragan, Cassandra M. Skinner, César Pacheco‐Tena, César Ramos-Remus, Juan Cruz Rizo Rodriguez, Seung-Jae Hong, Yeon-Ah Lee, Ji Hyeon Ju, Seong Wook Kang, Tae‐Hwan Kim, Chang Keun Lee, Eun Bong Lee, Sang Heon Lee, Min‐Chan Park, Kichul Shin, Sang‐Hoon Lee, Hung-An Chen, Ying‐Chou Chen, Song‐Chou Hsieh, Joung‐Liang Lan, Zdeněk Dvořák, Radka Moravcová, Martina Malcova, Yoshinori Taniguchi, Mitsumasa Kishimoto, Kurisu Tada, Hiroaki Dobashi, Kentaro Inui, Yukitaka Ueki, Yoshifuji Matsumoto, Yoshinobu Koyama, Kazuhiro Hatta, Tatsuya Atsumi, Midori Goto, Kiyoshi Matsui, Yuya Takakubo, Gunther Neeck, Denis Poddubnyy, Andrea Rubbert‐Roth, Malgorzata Szymańska, Tomasz Blicharski, Anna Dudek, Artur Racewicz, Rafał Wojciechowski, Marleen van de Sande, E. N. Griep, Mike Nurmohamed, Galina Matsievskaya, Е. Шмидт, Marina Stanislav, S. S. Yakushin, О. Б. Ершова, А. П. Ребров, Tibor Balázs, Regina Cseuz, Edit Drescher, Gyula Poór - The Lancet 2018 被引用: 359

  12. A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study)

    著者: Gerd R Burmester, Andrea Rubbert‐Roth, Alain Cantagrel, Stephen Hall, Piotr Leszczyński, Daniel Feldman, Madura J Rangaraj, Georgia Roane, Charles Ludivico, Peng Lü, Lucy Rowell, Min Bao, Eduardo Mysler - Annals of the Rheumatic Diseases 2013 被引用: 238

  13. Failure of anti-TNF treatment in patients with rheumatoid arthritis: The pros and cons of the early use of alternative biological agents

    著者: Andrea Rubbert‐Roth, Melinda Zsuzsanna Szabó, Melinda Kedves, György Nagy, Fabiola Atzeni, Piercarlo Sarzi‐Puttini - Autoimmunity Reviews 2019 被引用: 133

  14. Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial

    著者: Claudia Kedor, Joachim Listing, Jan Zernicke, Anja Weiß, Frank Behrens, Norbert Blank, Jörg Henes, Joern Kekow, Andrea Rubbert‐Roth, Hendrik Schulze‐Koops, Eva Seipelt, Christof Specker, Eugen Feist - Annals of the Rheumatic Diseases 2020 被引用: 99

  15. Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases

    著者: Olaf Schultz, F. Oberhäuser, Jasemine Saech, Andrea Rubbert‐Roth, Moritz Hahn, Wilhelm Krone, Matthias Laudes - PLoS ONE 2010 被引用: 224

  16. Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis

    著者: Andrea Rubbert‐Roth, Adriana María Kakehasi, Tsutomu Takeuchi, Marc Schmalzing, Hannah Palac, Derek Coombs, Jianzhong Liu, Samuel I. Anyanwu, Ralph Lippe, Jeffrey R. Curtis - Rheumatology and Therapy 2023 被引用: 23

  17. MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial

    著者: Frank Behrens, Paul P. Tak, Mikkel Østergaard, Румен Стоилов, Piotr Wiland, Thomas W Huizinga, V.Y. Berenfus, Stoyanka Vladeva, Jürgen Rech, Andrea Rubbert‐Roth, Mariusz Korkosz, Dmitriy Rekalov, И. А. Зупанец, Bo Ejbjerg, Jens Geiseler, Julia Fresenius, Roman Korolkiewicz, Arndt Schottelius, Harald Burkhardt - Annals of the Rheumatic Diseases 2014 被引用: 151

  18. Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative

    著者: Athan Baillet, Laure Gossec, Loreto Carmona, Maarten de Wit, Yvonne van Eijk‐Hustings, Heidi Bertheussen, Kent Alison, Mette Toft, Marios Kouloumas, Ricardo J O Ferreira, Susan Oliver, Andrea Rubbert‐Roth, Sander van Assen, William G Dixon, Axel Finckh, A. Zink, Joel M. Kremer, Tore K Kvien, Michael T. Nurmohamed, Désirée van der Heijde, Maxime Dougados - Annals of the Rheumatic Diseases 2016 被引用: 256

  19. Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)

    著者: Hans‐Peter Tony, Gerd R Burmester, Hendrik Schulze‐Koops, Mathias Grünke, J. Henes, Ina Kötter, Judith Haas, L. Unger, Svjetlana Lovric, Marion Haubitz, Rebecca Fischer‐Betz, Gamal Chehab, Andrea Rubbert‐Roth, Christof Specker, Jutta Weinerth, Julia U. Holle, Ulf Müller‐Ladner, Ramona König, Christoph Fiehn, Philip Burgwinkel, Klemens Budde, H. Sörensen, Michael J. Meurer, Martin Aringer, Bernd C. Kieseier, Cornelia Erfurt‐Berge, Michael Sticherling, Roland Veelken, Ulf Ziemann, Frank Strutz, Praxis von Wussow, Florian Meier, Nico Hunzelmann, Enno Schmidt, Raoul Bergner, Andreas Schwarting, Rüdiger Eming, Michael Hertl, Rudolf Stadler, Michael Schwarz-Eywill, Siegfried Wassenberg, Martin Fleck, Claudia Metzler, Uwe K. Zettl, J. Westphal, Stefan Heitmann, Anna Laura Herzog, Heinz Wiendl, Waltraud Jakob, Elvira Schmidt, Klaus Freivogel, Thomas Dörner, GRAID investigators - Arthritis Research & Therapy 2011 被引用: 208

  20. Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study

    著者: Atul Deodhar, Alice B. Gottlieb, Wolf‐­Henning Boehncke, Bin Dong, Yuhua Wang, Yanli Zhuang, William Barchuk, Xie L. Xu, Elizabeth C. Hsia, Jacob Aelion, Juan Amarelo-Ramos, Alejandro Balsa, Florian Berghea, Jan Brzezicki, Michael Burnette, Scott Fretzin, Sara García, Geoffrey Gladstein, Juan J. Gómez‐Reino, Melinda Gooderham, Carlos González, Alice B. Gottlieb, Jordi Gratacós, Derek Haaland, Rima KAMALOVA, Piotr Leszczyński, E. Martín‐Mola, Alexey Maslyansky, Federico Navarro, Daniela Opriș-Belinski, Kim Papp, Yu. N. Perlamutrov, Sandra Philipp, Artur Racewicz, А. П. Ребров, Maria Rell‐Bakalarska, David Rosmarin, Andrea Rubbert‐Roth, William Shergy, I. V. Shirinsky, Д. Л. Сонин, Marina Stanislav, А. Е. Сухарев, Vadim Temnikov, I. B. Vinogradova, Paul Waytz, Vladimir YAKUSHEVICH - The Lancet 2018 被引用: 184

  21. A randomised phase IIb study of mavrilimumab, a novel GM–CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis

    著者: Gerd R Burmester, Iain B. McInnes, Joel M. Kremer, Pedro C. Miranda, Mariusz Korkosz, Jiří Vencovský, Andrea Rubbert‐Roth, Eduardo Mysler, Matthew A. Sleeman, A. Godwood, Dominic Sinibaldi, Xiang Guo, Wendy I. White, Bing Wang, Chi‐Yuan Wu, Patricia C. Ryan, D. Close, Michael E. Weinblatt - Annals of the Rheumatic Diseases 2017 被引用: 126

  22. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

    著者: Josef S Smolen, Robert Landewé, Ferdinand C. Breedveld, Maya H Buch, Gerd Burmester, Maxime Dougados, Paul Emery, C. Gaujoux-Viala, Laure Gossec, J. Nam, Sofía Ramiro, Kevin Winthrop, Maarten de Wit, Daniel Aletaha, Neil Betteridge, J. W. J. Bijlsma, Maarten Boers, Frank Buttgereit, Bernard Combe, Maurizio Cutolo, Nemanja Damjanov, Johanna M. W. Hazes, Marios Kouloumas, Tore K Kvien, Xavier Mariette, Karel Pavelká, Piet L. C. M. van Riel, Andrea Rubbert‐Roth, Marieke Voshaar, David L. Scott, Tuulikki Sokka‐Isler, John B. Wong, Désirée van der Heijde - Annals of the Rheumatic Diseases 2013 被引用: 1,762

  23. Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial

    著者: Gerd R Burmester, William F. C. Rigby, Ronald van Vollenhoven, Jonathan Kay, Andrea Rubbert‐Roth, Ariella Kelman, Sophie Dimonaco, Nina Mitchell - Annals of the Rheumatic Diseases 2015 被引用: 196

  24. Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy

    著者: Andrea Amstad, Eleftherios Papagiannoulis, Almut Scherer, Andrea Rubbert‐Roth, Axel Finckh, Ruediger B. Müeller, Jean Dudler, Burkhard Möller, Peter M. Villiger, Martin M P Schulz, Diego Kyburz - Lara D. Veeken 2022 被引用: 36